Insys Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch INSYQ and buy or sell other stocks, ETFs, and their options commission-free!About INSYQ
Insys Therapeutics is a commercial-stage specialty pharmaceutical company that develops and commercializes innovative supportive care products. We have two marketed products, Subsys and Dronabinol SG Capsule, which leverage our sublingual spray drug delivery technology and dronabinol formulation and manufacturing capabilities, respectively.
CEOAndrew G. Long, MBA
CEOAndrew G. Long, MBA
Employees—
Employees—
HeadquartersChandler, Arizona
HeadquartersChandler, Arizona
Founded1990
Founded1990
Employees—
Employees—
INSYQ Key Statistics
Market cap3.13M
Market cap3.13M
Price-Earnings ratio-0.01
Price-Earnings ratio-0.01
Dividend yield—
Dividend yield—
Average volume119.08K
Average volume119.08K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$6.71
52 Week high$6.71
52 Week low$0.024
52 Week low$0.024
Stock Snapshot
As of today, Insys Therapeutics(INSYQ) shares are valued at $0.04. The company's market cap stands at 3.13M, with a P/E ratio of -0.01.
Insys Therapeutics(INSYQ) stock opened on 2025-12-09 at —. The price climbed to — and dipped to —.
Insys Therapeutics(INSYQ) shares are trading with a volume of 0, against a daily average of 119.08K.
During the past year, Insys Therapeutics(INSYQ) stock moved between $0.02 at its lowest and $6.71 at its peak.
During the past year, Insys Therapeutics(INSYQ) stock moved between $0.02 at its lowest and $6.71 at its peak.